Lawrence C. Best
Fondatore presso OXO Capital LLC
Posizioni attive di Lawrence C. Best
Società | Posizione | Inizio | Fine |
---|---|---|---|
OXO Capital LLC
OXO Capital LLC Financial ConglomeratesFinance OXO Capital LLC operates as an investment company. The firm holds securities of other firms for investment purposes. The company was founded by Lawrence C. Best in 2007 and is headquartered in Boston, MA. | Presidente | 01/01/2007 | - |
Fondatore | 01/01/2007 | - | |
4Tech Cardio Ireland Ltd.
4Tech Cardio Ireland Ltd. Medical SpecialtiesHealth Technology 4Tech Cardio Ireland Ltd. develops and manufactures surgical devices. The company was founded in 2011 and is headquartered in Waltham, MA. | Direttore/Membro del Consiglio | - | - |
NeoSync, Inc.
NeoSync, Inc. Medical SpecialtiesHealth Technology NeoSync, Inc. is a clinical-stage firm. It develops non-invasive neuromodulation products to treat major depressive disorder and other diseases of the central nervous system. The firm's technology, NeoSync-EEG Synchronized TMS, is personalized to a patient’s individual alpha frequency. The company was founded by Bill Phillips and is headquartered in South Boston, MA. | Presidente | - | - |
Storia della carriera di Lawrence C. Best
Precedenti posizioni note di Lawrence C. Best
Società | Posizione | Inizio | Fine |
---|---|---|---|
MYRIAD GENETICS, INC. | Direttore/Membro del Consiglio | 16/09/2009 | 04/12/2020 |
Independent Dir/Board Member | 16/09/2009 | 04/12/2020 | |
HAEMONETICS CORPORATION | Direttore/Membro del Consiglio | 01/01/2003 | 31/07/2014 |
Independent Dir/Board Member | 01/01/2003 | 31/07/2014 | |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | Direttore/Membro del Consiglio | 01/01/2003 | 31/12/2008 |
BOSTON SCIENTIFIC CORPORATION | Direttore Amministrativo | 01/01/2007 | 01/01/2007 |
Direttore Finanziario/CFO | 01/01/2007 | 01/01/2007 | |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/1981 | 01/01/1992 |
Cardiovalve Ltd.
Cardiovalve Ltd. Medical SpecialtiesHealth Technology Part of Venus Medtech (Hangzhou), Inc., Cardiovalve Ltd. is an Israeli medical device company that specializes in developing the Cardiovalve transcatheter system. The company is based in Or Yehuda, Israel. The system is designed to replace regurgitating mitral and tricuspid valves using a transfemoral-transseptal approach. The CEO of the company is Amir Gross. Cardiovalve was acquired by Athena Medtech Holding Ltd. on January 25, 2022 for $83.98 million. | Presidente | - | - |
░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░ | - | - | |
░░░ ░░░░░░░ ░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Formazione di Lawrence C. Best
Kent State University (Ohio) | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 13 |
Israele | 3 |
Irlanda | 2 |
Posizioni
Director/Board Member | 8 |
Chairman | 4 |
Independent Dir/Board Member | 2 |
Settori
Health Technology | 10 |
Commercial Services | 3 |
Finance | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 4 |
---|---|
HAEMONETICS CORPORATION | Health Technology |
BIOGEN INC. | Health Technology |
MYRIAD GENETICS, INC. | Health Technology |
BOSTON SCIENTIFIC CORPORATION | Health Technology |
Aziende private | 10 |
---|---|
Archemix Corp.
Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Archemix Corp. engages in the research and development of aptamer-based therapeutic products. It focuses in the areas of cardiovascular disease hematology, and oncology. The company was founded in May 2001 and is headquartered in Cambridge, MA. | Commercial Services |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | Finance |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
OXO Capital LLC
OXO Capital LLC Financial ConglomeratesFinance OXO Capital LLC operates as an investment company. The firm holds securities of other firms for investment purposes. The company was founded by Lawrence C. Best in 2007 and is headquartered in Boston, MA. | Finance |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Health Services |
4Tech Cardio Ireland Ltd.
4Tech Cardio Ireland Ltd. Medical SpecialtiesHealth Technology 4Tech Cardio Ireland Ltd. develops and manufactures surgical devices. The company was founded in 2011 and is headquartered in Waltham, MA. | Health Technology |
Valtech Cardio Ltd.
Valtech Cardio Ltd. Medical SpecialtiesHealth Technology Valtech Cardio Ltd. develops devices for mitral valve repair and replacement. It specializes in the development of devices for mitral and tricuspid valve repair and replacement. The firm also offers full in-house development, manufacturing and clinical research capabilities, and patent applications. The company was founded by Amir Gross and Yossi Gross in March 2005 and is headquartered in Or Yehuda, Israel. | Health Technology |
NeoSync, Inc.
NeoSync, Inc. Medical SpecialtiesHealth Technology NeoSync, Inc. is a clinical-stage firm. It develops non-invasive neuromodulation products to treat major depressive disorder and other diseases of the central nervous system. The firm's technology, NeoSync-EEG Synchronized TMS, is personalized to a patient’s individual alpha frequency. The company was founded by Bill Phillips and is headquartered in South Boston, MA. | Health Technology |
Cardiovalve Ltd.
Cardiovalve Ltd. Medical SpecialtiesHealth Technology Part of Venus Medtech (Hangzhou), Inc., Cardiovalve Ltd. is an Israeli medical device company that specializes in developing the Cardiovalve transcatheter system. The company is based in Or Yehuda, Israel. The system is designed to replace regurgitating mitral and tricuspid valves using a transfemoral-transseptal approach. The CEO of the company is Amir Gross. Cardiovalve was acquired by Athena Medtech Holding Ltd. on January 25, 2022 for $83.98 million. | Health Technology |
- Borsa valori
- Insiders
- Lawrence C. Best
- Esperienza